1. Home
  2. AXGN vs YDES Comparison

AXGN vs YDES Comparison

Compare AXGN & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axogen Inc.

AXGN

Axogen Inc.

N/A

Current Price

$32.19

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$7.80

Market Cap

894.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AXGN
YDES
Founded
N/A
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
894.2M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
AXGN
YDES
Price
$32.19
$7.80
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$36.11
N/A
AVG Volume (30 Days)
737.2K
12.0K
Earning Date
05-15-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$225,208,000.00
N/A
Revenue This Year
$19.81
N/A
Revenue Next Year
$16.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
20.21
N/A
52 Week Low
$9.22
$7.51
52 Week High
$36.00
$25.00

Technical Indicators

Market Signals
Indicator
AXGN
YDES
Relative Strength Index (RSI) 51.61 31.53
Support Level $29.13 N/A
Resistance Level $34.26 $9.46
Average True Range (ATR) 1.59 0.52
MACD -0.15 0.01
Stochastic Oscillator 54.85 12.31

Price Performance

Historical Comparison
AXGN
YDES

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: